Gallium-67 scintigraphy in multisystem malignant melanoma

Journal Article · Sat Jan 01 04:00:00 EST 1977 · Radiology; (United States)

OSTI ID:7227763

Jackson, F I; McPherson, T A; Lentle, B C

In a prospective study of the value of gallium-67 scintigraphy in cases of multisystem malignant melanoma, 69 scans were obtained for 36 patients. No abnormality was found in 18 scans; in only 3 was there other evidence of disease. Of 54 sites of disease demonstrated by scintigraphy, 40 were correlated with other investigations: biopsy (5), surgery (7), autopsy (7), radiographic (13), or clinical (8). Metastatic melanoma was found in 37 (69 percent) of the sites; no such disease was found in 3 (5.7 percent). The life expectancy of patients with an abnormal scan was shorter than that of patients with a normal scan. Gallium studies reliably indicated the extent of multisystem melanoma, and are of value in clinical management.

• Research Organization: W.W. Cross Cancer Inst., Edmonton, Can.
• OSTI ID: 7227763
• Journal Information: Radiology; (United States), Journal Name: Radiology; (United States) Vol. 122:1; ISSN RADLA
• Country of Publication: United States
• Language: English

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
DISTRIBUTION
ELECTRON CAPTURE RADIOISOTOPES
GALLIUM 67
GALLIUM ISOTOPES
INTERMEDIATE MASS NUCLEI
ISOTOPES
MEDICINE
MELANOMAS
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIONUCLIDE ADMINISTRATION
SCINTISCANNING
TISSUE DISTRIBUTION